Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Olysio drives J&J pharma sales

But hepatitis C drug set to face serious competition from Gilead Sciences

- PMLiVE

SMC recommends Novartis’ Gilenya for severe form of MS

Leads wave of drug reimbursement opinions in Scotland

- PMLiVE

Ashley Communications appoints Sarah Savage as director

She moves to the agency from WCG London

- PMLiVE

Pharmacy Voice names head of comms

Melissa Fife joins from Forster Communications

- PMLiVE

Changing behaviour with fast and slow thinking

Challenging the decision-making that underpins behaviour change

US approval for Philips’ telehealth applications

The programmes give clinicians real-time access to health data

National Institute for Health and Care Excellence NICE logo

NICE working to tackle antimicrobial resistance

Two guidelines in development to improve NHS use of antibiotic drugs

- PMLiVE

Pfizer’s palbociclib on track for early 2015 launch

Good news for the highly anticipated breast cancer drug

- PMLiVE

BMS and Janssen to assess PD1 cancer combination

Will test Opdivo and Imbruvica in non-Hodgkin lymphoma

- PMLiVE

Takeda appoints head of vaccines development

John Boslego will succeed Ralf Clemens

Sanofi reception

Sanofi unit takes low-cost rotavirus vaccine into phase III

Licensed vaccines still too expensive for countries hit hardest

- PMLiVE

One third of UK lung cancer patients die within three months of diagnosis

Study authors say GPs may not notice signs of disease early enough

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links